Neurotherapeutics

Neurotherapeutics is a startup drug development company using antibody engineering technologies to develop peptides, peptoids and mimetics acting on CNS membrane receptors.
Current focus is a memory/cognition enhancing drug which is a small peptide acting as partial agonist at glycine site of NMDA receptor, functionally active in-vitro and in-vivo.
Seek strategic alliances and other relationships with other Biotech companies with interests in NMDA receptor-acting drugs to engage in final development and development of other drugs.

Activity:

- Research & Development

Product / Technology type(s) covered:

- Bio
- Pharmaceuticals / Therapeutics
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: